What is the main business of Apteka Portowa?

The main business activity of Apteka Portowa focuses on dispensing chemist in specialised stores.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on May 20, 2002.

Where is the headquarters located?

The headquarters is located at: Kormoranów 44, 71-696 Szczecin.

Who is on the management board?

The management board consists of: Łukasz Knopf (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

How much revenue was generated?

In 2025, the company generated total revenue of $4,999, representing a decrease of 22.5% compared to 2024.

Is the company profitable?

Yes, the company recorded a net profit of $4,583 in 2025, meaning the company decreased its profit by 24.1%.

What is the largest operating cost?

The largest operating cost category falls under external services. This category amounted to $355 in 2025, representing 85% of all operating expenses.

Apteka Portowasp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2002-05-20

Share capital

5,000.00 PLN

Registered address

Kormoranów 44, 71-696 Szczecin, Poland

Electronic delivery address

AE:PL-43501-33985-FSGUJ-18

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 76 days for 2021).

202514/07/2026
202430/06/2025
202316/07/2024
202215/07/2023
202129/09/2022
202008/10/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 5.00kMedianUSD 1.92mAverageUSD 5.20m

Net profit

This companyUSD 4.58kMedianUSD 20.70kAverageUSD 86.70k

Operating costs

This companyUSD 416.17MedianUSD 1.88mAverageUSD 5.04m

Assets

This companyUSD 98.56kMedianUSD 543.65kAverageUSD 1.76m

Industry

Authorized Representatives

Łukasz Knopf – President of the Management Board

Manner of representation

Each member of the management board individually or the commercial proxy appointed by the management board is authorized to submit declarations of will concerning the company’s property rights and obligations and to sign agreements and obligations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Aleksander Knopfage 72	4	$540.25	40%
Łukasz Knopfage 44	6	$810.37	60%

Łukasz Knopf and Aleksander Knopf hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication date	Event
Jun 16, 2015	Call to creditors

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Ms-Pharmsp. z o.o. + limited partnership	$4,619,501.46	mspharm.pl
Eurekasp. z o.o.	$1,377,733.77	fundacja-eureka.edu.pl
Farmacja Im. O. Klimuszkisp. z o.o.	$1,289,548.20	zyj-zdrowo.com
Twoja Tania Apteka Farmarsp. z o.o.	$440,843.57	domlekow.pl
Nukloversp. z o.o.	$227,479.26	nuklover.com
Massmedsp. z o.o.	$49,747.70	mojoapps.co
Pharmer Polskasp. z o.o.	$15,884.06	punktapteczny.online
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.	$2,740.83	kwendasa.pl
Femaherbsp. z o.o.	$655.76	femaherb.com
Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-SzczecinS.A.	–	farmacol.com.pl

Change history

Date	Event
2016-03-04	Share capital reduction (50,000.00 PLN → 5,000.00 PLN)
2002-05-20	Entered in the register

FAQ

Last updated: 2026-07-23